CAGE Bio Initiates Phase 2 Study for Treatment of Rosacea. Now Enrolling!
A promising new approach for treating psoriasis — a topical lotion containing nucleic acids that transiently disrupt inflammatory gene activity.
A new class of hand sanitizers for a new threat.
A new ionic liquid formulation that killed cancer cells and allowed uniform distribution of a chemotherapy drug into liver tumors and other solid tumors in the lab.
Biotech Startup Announces R&D Collaboration With Major Japanese Drug Delivery Company
Emerging biotech company expands to HSC
Copyright © 2020 CAGE Bio Inc. - All Rights Reserved.
CAGE Bio Initiates Phase 2 Study for Treatment of Rosacea.